Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
about
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisManagement of bipolar depression with lamotrigine: an antiepileptic mood stabilizerSecond messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorderEfficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot studyThe MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular componentsLithium and bipolar mood disorder: the inositol-depletion hypothesis revisitedDecrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeksProtein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.Mood-stabilizers target the brain arachidonic acid cascade.Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effectsMolecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.Potential mechanisms of action of lithium in bipolar disorder. Current understanding.Lithium long-term treatment in mood disorders: clinical and genetic predictors.PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.NEUROBIOLOGY OF ADULT AND TEENAGE SUICIDEEmerging therapeutic targets in bipolar mood disorder.Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.Affective disorders, antidepressant drugs and brain metabolism.Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.Mood stabilizer psychopharmacologyVerapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.Intracellular signaling pathways pave roads to recovery for mood disorders.Neurobiology of bipolar disorder.Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?Tamoxifen use for the management of mania: a review of current preclinical evidence.Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium.Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro.Commentary on the nature and treatment of bipolar disorder.The pharmacogenetics of lithium response depends upon clinical co-morbidity.Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.The observed alteration in BCL2 expression following lithium treatment is influenced by the choice of normalization method.Molecular targets of lithium action
P2860
Q24651407-F362DA45-3DE8-4434-896E-C05D220CBA87Q26777966-7D52606A-B6A9-483C-BD35-599DB2B6D4B8Q27002419-89285237-4CB9-4B12-811A-AB036844A060Q28248076-08B582A0-B665-447F-AEE8-8177C7461FF4Q28253543-CD0E84E3-DFA0-4AAA-9032-A0FCAC35616FQ28294604-28AB53EF-5CBA-4BF3-A9E9-75F66E63B275Q28578836-D7F643DF-47D4-47B3-A257-2D8B8E9D2455Q33573983-8CAC3939-6285-4677-9A8B-4A92059FE4E3Q33671302-1E7BF68B-71D2-4296-89F7-DEC0853130B4Q33809252-B13FDEF7-1B65-4DFA-AE11-3FF455019934Q33929918-5E8C6E35-445F-4083-9372-CE4268AFDC47Q34180376-20C2E579-BE36-4554-BFAD-5D3877C27B85Q34185366-FA3686CD-1D0A-4763-99A9-2BF58C185E43Q34325612-EEDB85D4-D48C-4D7D-8FE7-FD8BB76B796CQ34609171-C192F249-D870-4075-B91C-C3509A80BBF8Q34622380-38A4C4B9-F5A0-4FEE-A69A-13229BCA7122Q34695129-3C3562B8-5D19-4D0F-8024-074CD45113DDQ35050429-45F5B39F-7404-41D2-B076-94CFEAB0F18FQ35101563-33E5BD54-9CC9-4F1E-A4B3-D4F2C0ED76D3Q35204087-A048B4F9-7C3B-4590-A6A7-459E70F6FE38Q35537239-9862D01B-E0EF-44E1-B70D-69017910A868Q35770186-048FD36F-64B8-4C43-99C8-7E22DD601486Q36010076-75B16724-C369-43EF-8F43-A6F560412DF8Q36031634-37C82A2F-D0FD-42A9-882F-3EF9DA1C41ABQ36070614-0F56DF56-FDFA-431E-A7F3-A1413DD318FAQ36939418-A1D73F0B-2698-4F43-89A5-9EC56397AE42Q37035241-CC4FA1C1-BF80-48DD-91EC-9C9474147739Q37461666-0025163F-7522-4B00-8910-BD791BC12B0EQ37943726-DA18391E-97E6-47D5-91F9-70C5CB192B76Q38179926-C4CCBB75-A05E-47D6-97A0-8DAEFD41C26CQ40766503-CDFE90F7-8008-42DB-88EB-7248DAE1F7BEQ43585245-3AF8AD11-B37C-4830-A38F-6ED0841F8F2AQ44315698-2935BDC8-6112-4F0D-9197-5A17A0E6A010Q45959644-D716874D-DB85-4C18-A715-11D74E734860Q47109377-245DC60D-E132-4151-B20E-F263EFA5658AQ55262536-D79080B9-5CCE-47E5-AD0D-86CA0F59C78FQ57612919-BC5568AD-06F9-495C-B1C6-56F89DDD69B8
P2860
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@en
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@nl
type
label
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@en
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@nl
prefLabel
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@en
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@nl
P2093
P1433
P1476
Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
@en
P2093
P304
P356
10.1016/0006-8993(92)90598-4
P407
P577
1992-01-01T00:00:00Z